Startup Spotlight: Delineate turns drug papers and plots into datasets for pharma models
Founded by Emily Nieves and Jawad Iqbal, Delineate says it has built datasets for pharma clients from hundreds of trials and thousands of published plots. Public customer counts differ, and its performance claims remain company-reported.
By RuntimeWire Staff · Published
Primary source: Y Combinator
Why it matters
Drug-development models are only as useful as the evidence assembled to build them. Delineate has published detailed examples of large datasets and enterprise work, while its customer counts and performance comparisons remain company-reported and its extraction accuracy has not been independently audited in the available sources.
Delineate, founded by Emily Nieves and Jawad Iqbal, builds software to turn pharmaceutical research into structured evidence for drug-development models and decisions. Before researchers can compare treatments or model dose and response, they must find and reconcile data scattered across papers, trial records, regulatory documents, conference materials, tables, and figures.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.